Lauren Biscaldi is the Managing Editor of Drug Topics.
FDA Approves Acoramidis for ATTR-CM
This approval marks the availability of the first near-complete stabilizer of transthyretin.
Exploring New Osteoarthritis Treatment Options | ACR Convergence
A number of new, nonopioid osteoarthritis treatment options are either available for patients or in the development pipeline.
Disconnect Between Adolescent, Caregiver Pain and Depression Symptoms in Rheumatic Diseases | ACR Convergence
PROMIS scores demonstrated the disparities between reported pain and mental health outcomes.
Reproductive Health Counseling and Education Crucial for Women With Rheumatic Disease | ACR Convergence
Despite an interest in services, a majority of women do not have these critical conversations with their health care providers.
Cervical Cancer Screening, HPV Vaccination Lacking In SLE | ACR Convergence
Systemic lupus erythematosus is associated with a higher risk of cervical dysplasia due to the inflammatory nature of the disease.
No Association Between High-Dose NSAIDs, Hypertension in axSpA | ACR Convergence
NSAIDS are typically the first line of treatment for axial spondyloarthritis.
Nonopioid Options to Manage Chronic Pain in Veterans | ACR Convergence
Chronic pain is more prevalent—and more severe—in veterans compared with the general US population.
Outcomes Vary When Cannabis Is Used for Pain Management in Rheumatic Disease | ACR Convergence
Investigators evaluated the role that cannabis plays in pain management in different populations with rheumatic diseases.
PMDD More Prevalent in RA, Leading to Worsened Mental Health | ACR Convergence
Premenstrual Dysphoric Disorder is considered a psychiatric disorder and is associated with moderate to severe physical, affective, and behavioral symptoms.
Despite Benefits, Mediterranean Diet Adherence in RA Remains Low | ACR Convergence
The Mediterranean diet is largely considered one of the healthiest diets.
Real-Time Pharmacist Feedback Improves Heart Failure Medication Management | AHA 2024
Results of a study at the Veterans Health Administration found that feedback and education led to better medication outcomes for patients.
Finerenone Safety, Efficacy for HFmrEF, HFpEF Evaluated by Sex
Study results are especially important for women, who are more likely to experience heart failure with mildly reduced or preserved ejection fraction.
Self-Management Behavioral Interventions May Improve Pain Outcomes in HIV
Researchers evaluated the efficacy of a self-managed intervention vs enhanced usual care.
Acoramidis Demonstrates Sustained Clinical Benefits in ATTR-CM
A PDUFA date for acoramidis has been set for November 29, 2024.
Maintenance Use of ADHD Therapies May Be Safe in Pregnancy
Continued methylphenidate or atomoxetine use may be safe, but additional studies are needed.
Community Pharmacists Crucial in RSV Vaccine Education Efforts
After shared decision making with their community pharmacist, patients were more likely to receive an RSV vaccine.
Evaluating the Safety of Tetracycline Use During the First Trimester of Pregnancy
As “therapeutic orphans,” pregnant women and their health care providers must balance the benefits of treatment with the risk of fetal harm.
Copayment Burden Affects Medication Adherence in Chronic Conditions
High copayments can be a structural barrier to medication therapy adherence.
Lumateperone Demonstrates Efficacy in Reducing Symptomatic Relapse Risk in Schizophrenia
The drug is also approved to treat schizophrenia and bipolar depression.
Hormonal Contraceptive Prescribing Benefits Patients, Pharmacies | NCPA 2024
With nearly 7 million women living in a health care desert, pharmacists can provide crucial reproductive care services.
Mid-Meeting Recap | NCPA 2024
The NCPA 2024 Annual Convention and Expo runs through October 29, 2024, in Columbus, Ohio.
Top Tips for Pharmacy Vaccination Clinics | NCPA 2024
Before marketing your pharmacy’s immunizations services, check out these takeaways from NCPA.
Finish The Fight: Patients Can Push PBM Reform Legislation Over the Finish Line | NCPA 2024
PBM reform legislation has progressed further in Congress than ever before.
ACIP Recommendations for Non-Respiratory Immunizations Remain Largely Unchanged | NCPA 2024
A second immunization session focused on updates in meningococcal disease, HPV, and Mpox.
2024 NCPA Digest Highlights Challenges in Independent Pharmacy | NCPA 2024
The digest was released at the NCPA 2024 Annual Convention and Expo.
How to Cash In On Your Pharmacy’s Front End | NCPA 2024
Making the store’s front end a priority can increase revenue opportunities and boost pharmacy profit.
Preparation, Cooperation Keys to Surviving a DEA Inspection | NCPA 2024
The Drug Enforcement Administration gives controlled substance licenses, and can just as easily take them away.
Key Recommendations for 2024-2025 Respiratory Virus Season | NCPA 2024
The first of a 2-part presentation focused on vaccines for COVID-19, flu, RSV, and pneumococcal disease.
ACIP Votes to Lower Recommended Age of Pneumococcal Vaccination
The new recommendations suggest vaccination at age 50, rather than age 65.
FDA Approves Abrysvo for Adults 18-59 at Increased Risk for RSV
Abrysvo is the only RSV vaccine approved for use in this age group.